Bayer invests USD 50 Million in eGenesis Series B financing round

Investment to support development of human-compatible xeno organs to address the global organ shortage crisis / eGenesis with lead program in kidney transplantation
Source: Bayer Company News - Category: Pharmaceuticals Source Type: news